FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Immunization, Passive
  • Immunoglobulin G
  • Neuroblastoma
  • Receptors, IgG

abstract

  • The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.

publication date

  • June 20, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.04.6011

PubMed ID

  • 16682723

Additional Document Info

start page

  • 2885

end page

  • 90

volume

  • 24

number

  • 18